These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35443671)

  • 1. Gastrointestinal Kohlmeier-Degos disease: a narrative review.
    Sattler SS; Magro CM; Shapiro L; Merves JF; Levy R; Veenstra J; Patel P
    Orphanet J Rare Dis; 2022 Apr; 17(1):172. PubMed ID: 35443671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the pathophysiologic basis of constrictive pericarditis of Kohlmeier Degos disease: A case series and review of the literature.
    Magro C; Shapiro L
    Ann Diagn Pathol; 2022 Aug; 59():151943. PubMed ID: 35588602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopy shows superiority over endoscopy for early detection of malignant atrophic papulosis gastrointestinal complications: a case report and review of literature.
    Toledo AE; Shapiro LS; Farrell JF; Magro CM; Polito J
    BMC Gastroenterol; 2015 Nov; 15():156. PubMed ID: 26527039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Eculizumab on the pathology of malignant atrophic papulosis.
    Magro CM; Wang X; Garrett-Bakelman F; Laurence J; Shapiro LS; DeSancho MT
    Orphanet J Rare Dis; 2013 Nov; 8():185. PubMed ID: 24279613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome.
    Magro CM; Poe JC; Kim C; Shapiro L; Nuovo G; Crow MK; Crow YJ
    Am J Clin Pathol; 2011 Apr; 135(4):599-610. PubMed ID: 21411783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of Degos disease: demonstration of C5b-9-mediated vascular injury.
    Umemura M; Miwa Y; Yanai R; Isojima S; Tokunaga T; Tsukamoto H; Takahashi R; Yajima N; Kasama T; Takahashi N; Sueki H; Yamaguchi S; Arai K; Takeuchi Y; Ohike N; Norose T; Yamochi-Onizuka T; Takimoto M
    Mod Rheumatol; 2015 May; 25(3):480-3. PubMed ID: 24506660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degos disease in a child presenting with acute renal failure.
    Ng PSM; Koh MJA
    Pediatr Dermatol; 2023 Mar; 40(2):394-395. PubMed ID: 36443642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant atrophic papulosis treated with eculizumab and hirudin: a fatal case report and literature review.
    Yu L; Wang Y; Tang X; Zhao X; Song Z
    Front Cardiovasc Med; 2024; 11():1347587. PubMed ID: 38606375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophic papulosis (Köhlmeier-Degos disease) revisited: a cross-sectional study on 105 patients.
    Kaleta KP; Jarienė V; Theodoridis A; Nikolakis G; Zouboulis CC
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2190-2194. PubMed ID: 35610757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Köhlmeier-Degos disease (Malignant Atrophic Papulosis): a cause of recurrent multiple intestinal perforations].
    Beuran M; Chiotoroiu AL; Morteanu S; Chilie A; Avram M; Roşu O; Vartic M; Creangă C; Mangrău A
    Chirurgia (Bucur); 2009; 104(6):765-72. PubMed ID: 20187481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant atrophic papulosis (Köhlmeier-Degos disease) - a review.
    Theodoridis A; Makrantonaki E; Zouboulis CC
    Orphanet J Rare Dis; 2013 Jan; 8():10. PubMed ID: 23316694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile dermatomyositis resembling late-stage Degos disease with gastrointestinal perforations successfully treated with combination of cyclophosphamide and rituximab: case-based review.
    Day W; Gabriel C; Kelly RE; Magro CM; Williams JV; Werner A; Gifford L; Lapsia SP; Aguiar CL
    Rheumatol Int; 2020 Nov; 40(11):1883-1890. PubMed ID: 31900501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrophic papulosis (Köhlmeier-Degos disease) in children and adolescents-A cross-sectional study and literature review.
    Zouboulis CC; Kaleta KP; Broniatowska E; Jarienė V; Nikolakis G
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):810-816. PubMed ID: 36606530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid associated intravenous and cutaneous microvascular drug abuse (skin-popping) masquerading as Degos disease (malignant atrophic papulosis) with multiorgan involvement.
    Magro CM; Toledo-Garcia A; Pala O; Momtahen S; Shapiro L
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of malignant atrophic papulosis (Köhlmeier-Degos disease) with treprostinil--early experience.
    Shapiro LS; Toledo-Garcia AE; Farrell JF
    Orphanet J Rare Dis; 2013 Apr; 8():52. PubMed ID: 23557362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary on 'Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome' by Magro et al: a reconsideration of Degos disease as hematologic or endothelial genetic disease.
    Scheinfeld N
    Dermatol Online J; 2011 Aug; 17(8):6. PubMed ID: 21906486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophic Papulosis.
    Robert M; Hot A
    Dermatology; 2023; 239(2):177-187. PubMed ID: 36353773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benign course of malignant atrophic papulosis (Köhlmeier-Degos disease): lack of vessel occlusion as good prognostic sign?].
    Wachter T; Rose C; Bröcker EB; Leverkus M
    J Dtsch Dermatol Ges; 2003 May; 1(5):374-7. PubMed ID: 16285303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant and benign forms of atrophic papulosis (Köhlmeier-Degos disease): systemic involvement determines the prognosis.
    Theodoridis A; Konstantinidou A; Makrantonaki E; Zouboulis CC
    Br J Dermatol; 2014 Jan; 170(1):110-5. PubMed ID: 24116834
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.